CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

IDT Provides Optimized Conditions for HDR in CRISPR Editing

As an advocate for the genomics age, Integrated DNA Technologies (IDT), has published a new application note on optimization of CRISPR-Cas9 for homology-directed repair (HDR) applications. Available as part of the IDT collection of CRISPR application notes and protocols, this article supports researchers using CRISPR in their genome editing studies to maximize HDR rate in knock-in and other short-insertion experiments.
 
Described as ‘true genome editing’, HDR is the most precise and error-free repair process available for breaks introduced in CRISPR experiments. However, due to the generally low baseline rate of HDR, optimizing reagents and experimental conditions becomes critical to maximize HDR-mediated insertions. This application note offers practical advice from IDT genomics experts, based on thorough optimization studies. This includes experiment planning, sequence design, preparation of reagents, delivery of CRISPR components, and verification of inserts.
 
This new resource adds to IDT’s extensive and continually updated library of genomics topics and underlines IDT’s commitment to developing new tools and techniques for genome editing and supporting scientists with up-to-date educational content for success in their work.
 
For more information, please visit www.idtdna.com, or follow IDT on twitter @idtdna for real-time updates and insights.
 

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026